vertex pharmaceuticals - patients and purpose
CFSource.com
CFSource.com provides pamphlets, quizzes, videos, and more resources for children and their caregivers to learn about CF.
TRIKAFTA
TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one copy of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Our goal was to share potential side effects with patients 18-26 in a fresh, engaging way.